Texas Yale Capital Corp. Novo Nordisk A S Transaction History
Texas Yale Capital Corp.
- $2.28 Billion
- Q3 2024
A detailed history of Texas Yale Capital Corp. transactions in Novo Nordisk A S stock. As of the latest transaction made, Texas Yale Capital Corp. holds 34,826 shares of NVO stock, worth $2.96 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
34,826
Previous 34,241
1.71%
Holding current value
$2.96 Million
Previous $4.89 Million
15.16%
% of portfolio
0.18%
Previous 0.23%
Shares
9 transactions
Others Institutions Holding NVO
# of Institutions
1,957Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.72 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.22 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.22 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.13 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.04 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $192B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...